Last 48 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 29.78 | 23.97 | 25.81 | 24.68 | 32.34 | 31.89 | 33.55 | 38.29 | 29.37 | 40.16 | 37.59 | — | 38.71 | 47.29 | 45.00 | 25.44 | 37.24 | — | 46.85 | 116.24 | 42.85 |
| — | -24.8% | -23.1% | -35.5% | +10.1% | -20.6% | -10.8% | — | -24.1% | -15.1% | -16.5% | — | +3.9% | — | -4.0% | -78.1% | -13.1% | — | — | +149.0% | +20.3% | |
| P/S Ratio | 3.99 | 3.23 | 3.45 | 3.42 | 4.19 | 4.19 | 4.27 | 3.78 | 3.71 | 4.53 | 4.26 | 4.98 | 4.21 | 4.40 | 4.72 | 3.44 | 3.80 | 3.46 | 4.49 | 5.03 | 5.07 |
| — | -22.9% | -19.1% | -9.4% | +12.8% | -7.5% | +0.1% | -24.1% | -11.8% | +2.8% | -9.6% | +44.8% | +10.6% | +27.2% | +5.1% | -31.7% | -25.1% | -19.4% | -7.4% | +7.3% | +0.7% | |
| P/B Ratio | 3.46 | 2.82 | 2.85 | 3.02 | 3.49 | 3.48 | 3.41 | 3.38 | 3.16 | 3.64 | 3.42 | 3.52 | 3.40 | 3.52 | 3.61 | 3.13 | 3.06 | 2.86 | 3.23 | 3.72 | 3.71 |
| — | -19.0% | -16.2% | -10.6% | +10.5% | -4.4% | -0.6% | -3.9% | -6.9% | +3.3% | -5.2% | +12.5% | +11.1% | +23.2% | +11.7% | -16.0% | -17.5% | -9.0% | +13.5% | -11.6% | -11.9% | |
| P/FCF | 26.24 | 24.09 | 18.43 | 22.19 | 31.39 | 30.36 | 18.18 | 29.47 | 20.87 | 40.40 | 27.88 | 34.02 | 31.69 | 86.83 | 26.02 | 32.98 | 40.66 | 197.36 | 44.82 | 61.75 | 37.60 |
| — | -20.7% | +1.4% | -24.7% | +50.4% | -24.8% | -34.8% | -13.4% | -34.1% | -53.5% | +7.2% | +3.1% | -22.0% | -56.0% | -42.0% | -46.6% | +8.1% | +262.2% | -60.8% | +70.4% | +40.1% | |
| EV / EBITDA | 17.01 | 18.40 | 13.54 | 13.29 | 16.97 | 16.80 | 17.46 | 18.03 | 15.16 | 19.62 | 20.21 | 16.73 | 17.13 | 18.35 | 18.80 | 15.02 | 16.34 | — | 19.87 | 20.96 | 21.59 |
| — | +9.5% | -22.5% | -26.3% | +12.0% | -14.4% | -13.6% | +7.8% | -11.5% | +7.0% | +7.5% | +11.4% | +4.8% | — | -5.4% | -28.3% | -24.3% | — | -64.7% | -4.3% | -1.8% | |
| EV / EBIT | 23.81 | 18.40 | 19.64 | 18.31 | 24.78 | 24.43 | 25.75 | 28.46 | 22.70 | 30.63 | 29.31 | 25.24 | 27.52 | 32.72 | 31.69 | 24.50 | 28.16 | — | 37.30 | 73.20 | 33.70 |
| — | -24.7% | -23.7% | -35.7% | +9.1% | -20.3% | -12.1% | +12.8% | -17.5% | -6.4% | -7.5% | +3.1% | -2.3% | — | -15.0% | -66.5% | -16.4% | — | — | +140.6% | +11.6% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.7% | 45.8% | 43.9% | 43.8% | 44.2% | 45.1% | 43.3% | 44.5% | 43.6% | 44.7% | 40.2% | 43.2% | 44.1% | 44.7% | 42.5% | 42.9% | 44.3% | 44.8% | 47.2% | 44.5% |
| — | +1.2% | +1.5% | +1.3% | -1.6% | +1.6% | +0.9% | +7.8% | +3.2% | -1.3% | +0.1% | -5.4% | +0.6% | -0.5% | -0.2% | -10.1% | -3.6% | +10.5% | +1.7% | +8.1% | +4.1% | |
| Operating Margin | 18.6% | 18.5% | 19.1% | 19.9% | 18.1% | 18.4% | 17.7% | 14.6% | 17.9% | 16.5% | 14.5% | 22.0% | 17.5% | 15.5% | 16.7% | 16.3% | 15.7% | -25.5% | 13.7% | 7.6% | 16.8% |
| — | +0.9% | +8.3% | +36.6% | +1.2% | +11.0% | +22.0% | -33.5% | +2.6% | +6.8% | -13.2% | +35.0% | +11.2% | +160.6% | +22.0% | +114.5% | -6.5% | -362.2% | +826.0% | -54.6% | -7.6% | |
| Net Margin | 13.2% | 13.5% | 13.4% | 13.9% | 12.9% | 13.1% | 12.8% | 9.8% | 12.7% | 11.3% | 11.4% | -0.1% | 10.8% | 9.3% | 10.4% | 13.5% | 10.2% | -26.3% | 9.6% | 4.3% | 11.9% |
| — | +2.4% | +5.1% | +41.0% | +1.8% | +16.4% | +12.2% | +8073.4% | +16.7% | +21.2% | +8.8% | -100.9% | +6.5% | +135.5% | +8.5% | +213.2% | -14.3% | -550.3% | +527.2% | -56.9% | -16.1% |
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.4% | 2.9% | 2.8% | 3.1% | 2.7% | 2.7% | 2.6% | 2.2% | 2.7% | 2.3% | 2.3% | -0.0% | 2.2% | 1.9% | 2.0% | 3.1% | 2.1% | -5.2% | 1.7% | 0.8% | 2.2% |
| — | +7.5% | +6.3% | +37.3% | +2.1% | +18.7% | +13.9% | +10440.3% | +19.3% | +24.0% | +13.8% | -100.7% | +6.9% | +136.2% | +17.4% | +288.7% | -4.3% | -584.7% | +512.3% | -64.7% | -28.2% | |
| ROA | 7.5% | 2.0% | 1.9% | 2.1% | 1.8% | 1.8% | 1.7% | 1.4% | 1.7% | 1.5% | 1.4% | -0.0% | 1.2% | 1.0% | 1.1% | 1.7% | 1.2% | -2.9% | 1.0% | 0.5% | 1.2% |
| — | +8.1% | +8.0% | +42.9% | +7.1% | +25.0% | +25.7% | +11948.4% | +38.3% | +41.1% | +20.1% | -100.7% | +6.5% | +135.9% | +16.2% | +283.0% | -5.1% | -597.0% | +521.5% | -66.0% | -35.4% | |
| ROIC | 9.4% | 2.5% | 2.4% | 2.7% | 2.3% | 2.3% | 2.1% | 1.9% | 2.1% | 1.9% | 1.5% | 1.9% | 1.8% | 1.5% | 1.6% | 1.9% | 1.6% | -2.5% | 1.3% | 0.7% | 1.6% |
| — | +9.4% | +14.7% | +43.2% | +9.7% | +21.8% | +38.3% | -1.7% | +20.2% | +22.6% | -5.8% | +2.8% | +9.2% | +160.3% | +28.6% | +159.8% | +3.4% | -387.1% | +805.1% | -64.2% | -29.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.28 | 0.28 | 0.29 | 0.29 | 0.29 | 0.30 | 0.33 | 0.36 | 0.36 | 0.39 | 0.54 | 0.55 | 0.59 | 0.51 | 0.53 | 0.54 | 0.55 | 0.50 | 0.50 | 0.53 |
| — | -3.8% | -4.6% | -12.9% | -20.6% | -19.3% | -23.9% | -37.9% | -33.9% | -38.2% | -22.8% | +0.4% | +1.5% | +6.6% | +1.9% | +6.5% | +1.8% | -1.1% | -14.9% | +8.2% | +9.9% | |
| Debt / EBITDA | 1.31 | 6.85 | 4.99 | 4.74 | 5.23 | 5.28 | 5.66 | 6.51 | 6.25 | 7.17 | 8.33 | 8.91 | 9.56 | 10.57 | 9.30 | 8.84 | 9.89 | — | 10.71 | 10.07 | 10.92 |
| — | +29.7% | -11.8% | -27.1% | -16.4% | -26.3% | -32.0% | -27.0% | -34.6% | -32.2% | -10.4% | +0.8% | -3.4% | — | -13.1% | -12.3% | -9.4% | — | -72.7% | +14.6% | +19.3% | |
| Current Ratio | 2.09 | 2.05 | 1.91 | 2.09 | 2.48 | 2.37 | 2.22 | 1.96 | 2.13 | 2.41 | 2.33 | 3.08 | 2.43 | 2.49 | 2.29 | 2.33 | 2.48 | 2.16 | 2.03 | 2.04 | 2.13 |
| — | -13.4% | -14.2% | +6.8% | +16.4% | -1.5% | -4.5% | -36.5% | -12.3% | -3.4% | +1.5% | +32.0% | -2.1% | +15.1% | +12.6% | +14.5% | +16.5% | -10.8% | +16.0% | -2.8% | -8.3% | |
| Quick Ratio | 1.54 | 1.44 | 1.35 | 1.54 | 1.75 | 1.63 | 1.53 | 1.39 | 1.40 | 1.55 | 1.49 | 2.36 | 1.49 | 1.55 | 1.42 | 1.63 | 1.61 | 1.42 | 1.35 | 1.41 | 1.47 |
| — | -11.4% | -11.6% | +10.9% | +24.8% | +5.0% | +2.7% | -41.1% | -6.1% | +0.1% | +4.6% | +44.4% | -7.3% | +8.8% | +5.3% | +15.5% | +9.3% | -16.5% | +9.4% | -8.9% | -15.5% | |
| Interest Coverage | 18.25 | 26.71 | 17.87 | 21.17 | 18.19 | 17.99 | 15.58 | 12.53 | 12.98 | 10.91 | 6.76 | 6.97 | 5.87 | 5.22 | 6.15 | 7.44 | 6.26 | -11.50 | 6.76 | 4.28 | 8.94 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STE stock.
STERIS plc's current P/E is 29.8x. The average P/E over the last 4 quarters is 26.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
STERIS plc's current operating margin is 18.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking STERIS plc's business trajectory between earnings reports.